OUR PIPELINE

We are a global team of scientists wholly dedicated to the study of cancer. Our focus in drug development is on disease pathways — or processes — that cancer cells depend on to survive. View pathways we are focusing on.

We have over 15 drug candidates in our pipeline. Explore a representation of our pipeline below to learn more. Download a PDF version of the pipeline.

ONCOLOGY DEVELOPMENT PIPELINE

* VELCADE® is co-developed by Millennium and Johnson & Johnson Pharmaceutical Research & Development

In-Licensed

SGN-35 is co-developed by Millennium and Seattle Genetics, Inc.

** Castration Resistant Prostate Cancer

§ Japan only development and marketing

All registered trademarks are the sole property of their respective owners. 7/26/13